The global injection pen market is anticipated to grow at a CAGR of 6.8% over the forecast period (2020-2026). The market is segmented on the basis of type and disorder type. Based on the disorder type, the market is segmented into diabetes, hormonal disorders, arthritis, and others. The diabetes segment of the market is estimated to witness significant growth in the market. The key aspects that drive the segmental growth of the injection pen market include the increased incidences of autoimmune disorders primarily diabetes and arthritis among the people across the globe.
Browse the full report description of "Global Injection Pen Market Size, Share & Trends Analysis Report by Type (Reusable and Disposable), by Disorder Type (Autoimmune Disorder, Hormonal Disorders, Orphan Disease, and Others), and Forecast 2020-2026" at https://www.omrglobal.com/industry-reports/injection-pen-market
There has been an upsurge witnessed in the prevalence of diabetes across the globe. As per the WHO, diabetes prevalence has been increasing steadily over the past three decades. In 2019, the diabetic population was nearly 463 million which is expected to rise to 578 million by 2030 as per the IDF, which will further raise to 700 million by 2045. These numbers specify an increase in the prevalence of diabetes which will demand the proper treatment options including insulin. Thus, owing to the higher demand for safe insulin delivery devices, the segment is likely to witness an upsurge over the forecast period.
Market Coverage
Key questions addressed by the report
Global Injection Pen Market – Segmentation
By Type
By Disorder Type
Global Injection Pen Market – Segmentation by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/injection-pen-market